SEC Company Response from Pulmatrix, Inc. (PULM) (CIK 0001574235) (PULM) — Nov 18, 2013
Pulmatrix, Inc. (PULM) (CIK 0001574235)
Date: Nov. 18, 2013 · CIK: 0001574235 · Accession: 0001144204-13-062796
AI Filing Summary & Sentiment
File numbers found in text: 333-190476
Letter
Ruthigen, Inc.
2455 Bennett Valley Rd., Suite C116
Santa Rosa, California 95404
November 18, 2013
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Riedler, Assistant Director
Re: Ruthigen, Inc.
Registration Statement on Form S-1
File No. 333-190476
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, Ruthigen, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-190476), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. (Washington, D.C. time) on November 20, 2013, or as soon thereafter as practicable. Under separate cover, you will receive a letter from the managing underwriter of the proposed offering joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
The Registrant hereby acknowledges that:
(i)
should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii)
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii)
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[remainder of page intentionally left blank]
Please call Linda K. Rockett (617-348-4888) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Company, with any comments or questions regarding this matter.
Very truly yours,
Ruthigen, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Ruthigen, Inc.
2455 Bennett Valley Rd., Suite C116
Santa Rosa, California 95404
November 18, 2013
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Riedler, Assistant Director
Re: Ruthigen, Inc.
Registration
Statement on Form S-1
File
No. 333-190476
Request
for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461
of Regulation C promulgated under the Securities Act of 1933, as amended, Ruthigen, Inc. (the “Registrant”) hereby
requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-190476), as amended (the
“Registration Statement”), so that it may become effective at 4:00 p.m. (Washington, D.C. time) on November 20, 2013,
or as soon thereafter as practicable. Under separate cover, you will receive a letter from the managing underwriter of the proposed
offering joining in the Registrant’s request for acceleration of the effectiveness of the Registration Statement.
The Registrant hereby acknowledges that:
(i)
should the U.S. Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(ii)
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(iii)
the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[remainder of page intentionally left
blank]
Please
call Linda K. Rockett (617-348-4888) of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.,
counsel to the Company, with any comments or questions regarding this matter.
Very truly yours,
Ruthigen, Inc.
By:
/s/ Hojabr Alimi
Name:
Hojabr Alimi
Title:
Chief Executive Officer, Chief Science Officer and
Chairman of the Board of Directors
cc: Securities and Exchange Commission
Jeffrey Riedler, Assistant
Director
Ibolya Ignat
Mark Brunhofer
Amy Reischauer
Daniel Greenspan
Ruthigen, Inc.
Hojabr Alimi,
Chief Executive Officer, Chief Science Officer and
Chairman of the Board of Directors
Sameer Harish, Chief Financial Officer
Mintz, Levin,
Cohn, Ferris, Glovsky and Popeo, P.C.
Ivan
K. Blumenthal, Esq.
Linda
K. Rockett, Esq.
Sichenzia Ross
Friedman Ference LLP
Jeffrey J. Fessler,
Esq.
Stephen A. Cohen, Esq.
Marcum LLP
Anthony Basile
Mitchell Watt